Ultrafiltration
System
Wave Bioreactor
Magnetic Stirrer
System
Vial Filling Line
Isolator System
Overall Solution Provider
BFS System
PFS Inspection System
Secondary Packaging System
GlaxoSmithKline will be the most affected, as it represents 26% of the potentially impacted drugs. This is followed by Novartis at 14%, Sanofi at 11%, and both Pfizer and Bayer with 8%.